This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of gallbladder
C3_GALLBLADDER
gallbladder neoplasm: A neoplasm (disease) that involves the gall bladder.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
174 |
4. Check minimum number of eventsNone |
174 |
5. Include endpointsNone |
174 |
6. Filter based on genotype QC (FinnGen only) |
172 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of gallbladder
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of gallbladder, including Hilmo
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo
- Malignant neoplasm of digestive organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 172 | 108 | 64 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | 72.96 | 73.02 | 72.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 174
- Matched controls
- 1740
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
213.2
158
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
121.5
102
*
130
Kela drug reimbursment
Malignant tumour
+∞
105.2
90
*
Z51.5
ICD-10 Finland
Palliative care
35.1
89.7
62
27
A03FA01
ATC
metoclopramide; systemic, rectal
15.3
76.0
97
132
WX302
NOMESCO Finland
Thoracal epidural anesthesy
38.0
63.3
41
14
H02AB02
ATC
dexamethasone; systemic
155.0
53.4
54
5
A04AA02
ATC
granisetron; systemic, transdermal
+∞
52.8
48
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
50.5
46
*
L01BC06
ATC
capecitabine; oral
+∞
49.3
45
*
N02AA05
ATC
oxycodone; systemic
9.1
47.8
87
172
UJK02
NOMESCO Finland
ERCP
20.6
43.0
35
21
JKA20
NOMESCO Finland
Cholecystectomy
18.1
39.3
34
23
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
108.9
33.1
35
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.6
33.1
45
61
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
32.3
30
*
JN4BD
NOMESCO Finland
Extensive body CT
11.2
31.5
37
41
8000/3-C23.9
ICD-O-3
Neoplasm, malignant of gallbladder
+∞
31.2
29
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
331.9
28.6
28
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
53.5
26.5
31
7
A04AA01
ATC
ondansetron; systemic, rectal
30.9
26.5
35
14
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
6.2
24.6
52
112
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.3
24.0
29
33
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.3
24.0
29
33
WZC00
NOMESCO Finland
Treatment plan or consultation
4.9
23.2
74
227
K83.0
ICD-10 Finland
Cholangitis
43.3
21.5
26
7
JN4AD
NOMESCO Finland
Body CT examination
8.2
21.1
31
45
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
125.1
21.1
22
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
20.2
19
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
20.2
19
*
JN4CD
NOMESCO Finland
Very extensive body CT
30.3
19.8
26
10
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
4.8
18.0
50
134
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
106.0
17.9
19
*
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
7.7
17.1
26
39
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
26.3
16.9
23
10
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.9
16.9
28
22
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
16.9
15.9
25
17
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.8
14
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
14.8
14
*
K83.1
ICD-10 Finland
Obstruction of bile duct
24.9
14.6
20
9
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
81.3
13.8
15
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
13.4
35
88
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
12.7
34
87
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.7
12
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
12.7
12
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
12.7
12
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
12.7
12
*
A06AH03
ATC
naloxegol; oral
139.7
12.6
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
12.0
59
231
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
25.0
11.8
16
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
11.6
35
98
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
16.6
11.6
18
12
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
+∞
11.6
11
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
116.8
10.5
11
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
10.5
10
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
10.5
10
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
18.1
10.1
15
9
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
27.9
10.0
13
5
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
27.9
10.0
13
5
A07EC02
ATC
mesalazine; oral, rectal
5.8
9.9
19
36
WX402
NOMESCO Finland
General anaesthesia
3.5
9.8
39
132
WZC30
NOMESCO Finland
Teaching
3.7
9.6
34
106
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.5
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.5
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.5
9.4
20
26
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
52.7
8.8
10
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
8.6
8.6
18
23
B01AB05
ATC
enoxaparin; parenteral
2.6
8.4
69
348
K82.9
ICD-10 Finland
Disease of gallbladder, unspecified
+∞
8.4
8
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
8.4
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
A05AA02
ATC
ursodeoxycholic acid; oral
13.9
8.0
13
10
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.9
8.0
45
186
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.7
7.8
16
20
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
47.1
7.8
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
83.5
7.5
8
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
83.5
7.5
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
7.5
29
96
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.0
7.4
14
15
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
7.3
7
*
8010/3-C23.9
ICD-O-3
Carcinoma, NOS, of gallbladder
+∞
7.3
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
JAH00
NOMESCO Finland
Laparotomy
10.7
7.2
13
13
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
7.1
49
224
B01AB10
ATC
tinzaparin; parenteral
3.8
7.1
23
67
ZX120
NOMESCO Finland
Intravenous
4.1
6.9
20
54
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
41.7
6.8
8
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
6.6
33
127
K81.0
ICD-10 Finland
Acute cholecystitis
7.9
6.6
14
19
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
6.4
30
111
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
6.3
6
*
L02BG04
ATC
letrozole; oral
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
6.3
6
*
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
5.6
6.2
17
33
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
6.2
34
138
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
9.1
6.2
12
14
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
10.6
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
12
48.74
72.66
3.5
1.6
829.75
311.05
u/ml
0.25
44
12
59
117
7.12
30.87
8.0
1.9
28.65
6.56
umol/l
1.70
54
102
48
89
7.07
26.51
3.9
2.0
0.19
0.21
g/l
1.03
48
78
115
623
3.49
14.02
24.3
3.4
24.11
11.82
umol/l
1.85
115
581
36
97
4.42
12.60
6.7
5.2
5.92
10.70
mmol/l
6.11
36
89
95
524
2.79
10.09
3.1
2.1
—
—
—
0
0
107
654
2.65
8.87
14.1
15.5
1.23
1.34
inr
0.83
39
176
58
263
2.81
8.78
2.5
1.9
—
—
—
0
0
103
655
2.40
7.32
20.6
5.6
4.12
4.34
e9/l
0.47
98
556
14
25
5.99
5.50
1.4
1.2
—
—
—
0
0
97
1243
0.50
4.61
4.5
5.0
5.92
6.07
mmol/l
0.72
88
1116
35
166
2.39
4.59
2.2
2.2
25.07
22.27
%
0.46
29
146
12
23
5.52
4.55
1.7
1.3
46.08
31.67
umol/l
0.38
12
18
95
1212
0.52
4.17
4.9
4.8
4.75
4.55
mmol/l
0.88
81
1103
100
1251
0.53
4.01
4.9
5.5
2.72
2.63
mmol/l
0.42
84
1128
91
644
1.87
3.97
5.8
4.8
1.20
1.22
mmol/l
2.73
78
567
95
1200
0.54
3.80
4.6
4.8
1.50
1.51
mmol/l
0.04
82
1087
37
202
2.06
3.42
1.8
1.6
—
—
—
0
0
95
1182
0.57
3.29
5.3
6.6
40.39
41.03
mmol/mol
0.24
81
1090
6
7
8.82
3.29
2.7
1.0
—
—
—
0
0
93
1161
0.57
3.22
4.4
4.3
1.27
1.24
mmol/l
0.14
81
1039
36
200
2.01
3.17
2.4
2.1
13.41
12.61
umol/l
0.24
36
181
12
37
3.41
3.00
3.3
1.4
54.83
40.34
u/ml
0.19
12
37
118
955
1.73
2.86
26.7
5.0
158.42
76.10
u/l
7.20
118
864
18
349
0.46
2.57
1.8
1.7
1.10
1.27
mmol/l
0.66
13
287
96
1158
0.62
2.47
4.3
5.1
2.04
1.94
mu/l
0.33
87
1047
7
17
4.24
2.38
1.3
1.2
—
—
—
0
0
12
47
2.67
2.32
1.6
1.5
1.01
2.59
ug/l
0.91
12
40
119
1356
0.61
2.24
48.8
19.9
36.83
39.80
%
6.36
108
1239
119
1356
0.61
2.24
48.7
20.1
121.44
133.29
g/l
12.95
119
1326
18
88
2.17
2.20
2.0
1.6
—
—
—
0
0
23
124
1.99
2.20
5.0
3.2
—
—
—
0
0
6
14
4.40
2.17
1.3
1.4
—
—
—
0
0
26
148
1.89
2.13
5.0
5.4
1.35
1.73
mmol/l
0.26
20
120
9
31
3.00
2.10
1.2
1.3
—
—
—
0
0
9
31
3.00
2.10
1.2
1.3
—
—
—
0
0
26
151
1.85
2.01
1.8
1.6
—
—
—
0
0
18
92
2.07
1.98
4.4
3.1
1.22
1.22
mmol/l
0.01
18
78
7
22
3.27
1.90
1.1
2.5
61.43
63.45
%
—
7
22
0
46
0.00
1.73
0.0
1.4
—
—
—
0
0
25
151
1.77
1.71
1.6
1.7
—
—
—
0
0
6
19
3.23
1.67
1.2
1.3
—
—
—
0
0
117
1308
0.68
1.55
41.7
16.1
71.06
78.30
umol/l
3.71
117
1308
0
42
0.00
1.55
0.0
1.2
—
2.95
—
0
8
0
44
0.00
1.53
0.0
1.2
—
—
—
0
0
5
15
3.40
1.53
1.2
1.3
113.00
68.16
pmol/l
—
5
15
9
39
2.38
1.45
1.3
1.2
—
—
—
0
0
6
22
2.79
1.44
1.2
1.1
—
—
—
0
0
25
159
1.67
1.44
6.2
4.3
104.64
104.25
mmol/l
0.20
25
159
45
332
1.48
1.39
5.2
4.4
0.00
0.00
estimate
-0.00
20
94
9
42
2.20
1.36
1.6
1.4
—
—
—
0
0
81
953
0.72
1.34
3.5
4.1
15.51
15.10
pmol/l
0.60
74
856
91
1046
0.73
1.26
40.3
16.1
15.01
15.02
%
0.01
91
1017
119
1306
0.72
1.17
29.8
9.2
34.43
23.72
u/l
5.93
119
1247
8
39
2.10
1.17
1.5
1.3
—
—
—
0
0
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
46
358
1.39
1.06
2.5
2.9
0.67
0.42
e6/l
0.44
39
252
67
557
1.33
1.01
3.7
4.0
48.32
94.65
ng/l
0.32
56
415
50
609
0.75
0.94
2.0
2.1
94.27
95.27
pmol/l
0.06
32
274
106
1156
0.79
0.78
31.7
12.8
79.81
73.05
ml/min/173m2
3.10
98
917
55
460
1.29
0.77
2.8
2.9
—
—
—
0
0
12
177
0.65
0.67
2.0
2.6
0.96
0.75
ug/l
—
6
114
11
72
1.56
0.60
5.3
5.9
0.70
0.73
%
0.16
11
72
11
72
1.56
0.60
5.2
6.0
1.53
1.43
%
0.11
11
72
10
64
1.60
0.60
4.8
5.5
24.52
25.07
mmol/l
—
10
64
8
53
1.53
0.59
1.1
1.1
9.09
10.66
g/l
—
8
47
25
195
1.33
0.58
1.6
1.6
31.06
29.35
s
0.64
25
187
8
54
1.50
0.58
1.1
1.1
3.19
3.01
g/l
—
8
48
6
37
1.64
0.56
3.7
3.6
—
—
—
0
0
56
488
1.22
0.54
4.7
4.3
—
—
—
0
0
51
584
0.82
0.53
2.1
2.3
—
—
—
0
0
85
927
0.84
0.52
4.4
4.4
21.14
13.56
mm/h
2.69
79
834
11
154
0.70
0.49
2.7
2.4
1.61
7.07
ug/l
2.39
11
136
8
57
1.42
0.43
1.1
1.1
7.59
7.70
g/l
—
8
51
8
57
1.42
0.43
1.1
1.1
3.82
3.70
g/l
—
8
51
8
57
1.42
0.43
1.1
1.1
—
—
—
0
0
14
105
1.36
0.42
2.4
1.2
65.14
66.57
g/l
0.27
14
92
5
33
1.53
0.41
2.2
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
322.00
—
0
5
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
6
46
1.32
0.33
1.2
1.1
0.00
0.10
g/l
—
6
41
12
92
1.33
0.33
6.0
1.9
66.29
57.58
ml/min/173m2
—
7
31
6
47
1.29
0.32
1.2
1.1
34.75
37.63
g/l
—
6
41
27
313
0.84
0.32
4.9
3.9
1.97
1.93
ug/l
0.04
20
274
36
320
1.16
0.28
1.5
1.7
439.57
453.98
pmol/l
0.19
28
251
13
158
0.81
0.25
4.5
4.8
31.37
32.01
%
—
8
104
10
79
1.28
0.23
1.7
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
26.80
—
0
5
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
25
279
0.88
0.19
1.4
1.6
1.22
1.21
mg/l
0.01
18
218
9
81
1.12
0.15
1.3
1.5
—
—
—
0
0
34
317
1.09
0.13
4.1
4.1
101.04
258.21
ng/l
0.79
25
279
66
635
1.06
0.11
4.4
4.1
0.00
0.00
estimate
-0.00
22
95
65
627
1.06
0.10
4.4
4.1
0.00
0.00
estimate
-0.00
23
102
16
145
1.11
0.09
1.0
1.3
—
—
—
0
0
5
64
0.77
0.08
1.0
1.2
—
118.99
—
0
20
29
306
0.94
0.07
1.9
1.8
1288.00
1184.26
nmol/l
0.24
24
237
15
140
1.08
0.04
1.4
1.3
—
—
—
0
0
64
628
1.03
0.04
5.0
5.5
0.00
0.00
estimate
-0.00
21
90
24
249
0.96
0.03
3.2
3.5
24.73
23.92
%
—
10
115
15
158
0.94
0.02
13.3
7.8
—
—
—
0
0
49
484
1.02
0.00
2.0
2.7
958.17
1732.30
ng/l
1.52
44
396
21
215
0.97
0.00
2.2
2.7
5.90
4.10
e6/l
—
10
112
22
222
0.99
0.00
2.1
2.5
1.18
1.27
e6/l
0.05
11
117
0
5
0.00
-0.00
0.0
1.4
—
30.34
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
11.40
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
111.82
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
1.6
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_GALLBLADDER – Malignant neoplasm of gallbladder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).